Cargando…

Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection

BACKGROUND: Viral suppression and viral breakthrough impact the humoral immune response to HIV infection. We evaluated the impact of viral suppression and viral breakthrough on results obtained with two cross-sectional HIV incidence assays. METHODS: All samples were collected from adults in the US w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wendel, Sarah K., Mullis, Caroline E., Eshleman, Susan H., Blankson, Joel N., Moore, Richard D., Keruly, Jeanne C., Brookmeyer, Ron, Quinn, Thomas C., Laeyendecker, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577851/ https://www.ncbi.nlm.nih.gov/pubmed/23437058 http://dx.doi.org/10.1371/journal.pone.0055525

Ejemplares similares

Pregnancy Does Not Affect HIV Incidence Test Results Obtained Using the BED Capture Enzyme Immunoassay or an Antibody Avidity Assay
por: Laeyendecker, Oliver, et al.
Publicado: (2010)

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller
por: Walker-Sperling, Victoria E., et al.
Publicado: (2017)

HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression
por: Kammers, Kai, et al.
Publicado: (2021)

Performance of a Limiting-Antigen Avidity Enzyme Immunoassay for Cross-Sectional Estimation of HIV Incidence in the United States
por: Konikoff, Jacob, et al.
Publicado: (2013)

Antibody Maturation and Viral Diversification in HIV-Infected Women
por: James, Maria M., et al.
Publicado: (2013)

Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
por: Laeyendecker, Oliver, et al.
Publicado: (2018)

A Case Report of Multiclass HIV Drug-Resistance After an Inappropriate Switch of ARVs with Persistent Unsuppressed Viral Load
por: Kakubu, Mireille A Mpalang, et al.
Publicado: (2022)

Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies
por: Woldemeskel, Bezawit A., et al.
Publicado: (2020)

A Comparison of Methods for Analyzing Viral Load Data in Studies of HIV Patients
por: Rose, Charles E., et al.
Publicado: (2015)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs
por: Metcalf Pate, Kelly A., et al.
Publicado: (2017)

Women and ARV-based HIV prevention – challenges and opportunities
por: Geary, Cynthia W, et al.
Publicado: (2014)

Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load
por: Grant-McAuley, Wendy, et al.
Publicado: (2023)

Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy
por: Gisslén, Magnus, et al.
Publicado: (2012)

Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?
por: Jao, Jennifer, et al.
Publicado: (2016)

Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya
por: Ng'ong'a, Gabriel O., et al.
Publicado: (2022)

ARV-based HIV prevention for women – where we are in 2014
por: Mastro, Timothy D, et al.
Publicado: (2014)

Comprehensive Profiling of HIV Antibody Evolution
por: Eshleman, Susan H., et al.
Publicado: (2019)

48. Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic
por: El-Nahal, Walid, et al.
Publicado: (2021)

A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation
por: Cousins, Matthew M., et al.
Publicado: (2014)

HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies
por: Kiwelu, Ireen E., et al.
Publicado: (2012)

A CD3/CD28 microbead-based HIV-1 viral outgrowth assay
por: Kuzmichev, Yury V, et al.
Publicado: (2017)

HIV-1 Transmitting Couples Have Similar Viral Load Set-Points in Rakai, Uganda
por: Hollingsworth, T. Déirdre, et al.
Publicado: (2010)

ARVs: The Next Generation. Going Boldly Together to New Frontiers of HIV Treatment
por: Barnhart, Matthew, et al.
Publicado: (2015)

364. Association of Maternal ARV Use with Microcephaly in HIV-Exposed Uninfected Children
por: Williams, Paige L, et al.
Publicado: (2019)

Breakthroughs and challenges in the management of pediatric viral hepatitis
por: Nicastro, Emanuele, et al.
Publicado: (2021)

Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy
por: Easterbrook, Philippa J, et al.
Publicado: (2010)

Subtype-associated differences in HIV-1 reverse transcription affect the viral replication
por: Iordanskiy, Sergey, et al.
Publicado: (2010)

Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load
por: Zhao, Lele, et al.
Publicado: (2022)

Engaging the community of women living with HIV to tailor and accelerate ARV research for pregnant and breastfeeding women
por: Clayden, Polly, et al.
Publicado: (2022)

1508. The effects of the COVID-19 pandemic on depression severity and viral load non-suppression among people with HIV accessing care in an urban infectious disease clinic in Baltimore, MD
por: Verinumbe, Tarfa, et al.
Publicado: (2023)

Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
por: Laird, Gregory M., et al.
Publicado: (2013)

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients
por: Baril, Jean-Guy, et al.
Publicado: (2016)

Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes
por: Duong, Yen T., et al.
Publicado: (2015)

A9 HIV subtype diversity across geography and transmission groups in Maryland
por: German, D, et al.
Publicado: (2018)

Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection
por: Novitsky, Vladimir, et al.
Publicado: (2011)

Patterns and rates of viral evolution in HIV-1 subtype B infected females and males
por: Dapp, Michael J., et al.
Publicado: (2017)

Maintenance of viral suppression in HIV-1–infected HLA-B*57(+) elite suppressors despite CTL escape mutations
por: Bailey, Justin R., et al.
Publicado: (2006)

High Avidity CD8(+) T Cells Efficiently Eliminate Motile HIV-Infected Targets and Execute a Locally Focused Program of Anti-Viral Function
por: Foley, Maria Hottelet, et al.
Publicado: (2014)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e03qqn47l89906kkavvovjl7u1